Literature DB >> 20371283

Tetramethylpyrazine inhibits production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through blockade of MAPK and PI3K/Akt signaling pathways, and suppression of intracellular reactive oxygen species.

Hong-Tao Liu1, Yu-Guang Du, Jun-Lin He, Wen-Juan Chen, Wen-Ming Li, Zhu Yang, Ying-Xiong Wang, Chao Yu.   

Abstract

AIM OF THE STUDY: To determine the inhibitory effect of tetramethylpyrazine (TMP) on lipopolysaccharide (LPS)-induced over-production of nitric oxide (NO) and inducible nitric oxide synthase (iNOS) in N9 microglial cells.
MATERIALS AND METHODS: N9 cells were pretreated with vehicle or TMP and then exposed to LPS for the time indicated. Cell viability was determined by methylthiazoyltetrazolium (MTT) assay. Nitrite assay was performed by Griess reaction. Expression of iNOS mRNA was examined by RT-PCR. Protein levels of iNOS, p38 mitogen-activated protein kinase (MAPK), ERK1/2, JNK, phosphatidylinositol 3-kinase (PI3K) and Akt were determined by western blot analysis. Formation of reactive oxygen species (ROS) was evaluated by fluorescence image system.
RESULTS: TMP inhibited LPS-induced over-production of NO and iNOS in N9 cells. TMP also inhibited the NF-kappaB translocation from cytoplasm into nucleus of N9 cells. In addition, TMP showed blocking effect on the phosphorylation of p38 MAPK, ERK1/2, JNK and Akt, but not PI3K. Further, TMP suppressed the formation of intracellular ROS in LPS-induced N9 cells.
CONCLUSIONS: TMP inhibited production of NO and iNOS in LPS-induced N9 cells through blocking MAPK and PI3K/Akt activation and suppressing ROS production. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371283     DOI: 10.1016/j.jep.2010.03.037

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  18 in total

1.  Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro.

Authors:  Peng Wei; Pan Ma; Qing-Song Xu; Qun-Hua Bai; Jian-Guo Gu; Hao Xi; Yu-Guang Du; Chao Yu
Journal:  Glycoconj J       Date:  2012-05-24       Impact factor: 2.916

2.  Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-κB Signaling in BV-2 Microglial Cells.

Authors:  Seung-Hwan Kwon; Shi-Xun Ma; Sa-Ik Hong; Seok-Yong Lee; Choon-Gon Jang
Journal:  J Med Food       Date:  2015-04-21       Impact factor: 2.786

3.  TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.

Authors:  Xiaoling Liang; Huanjiao Zhou; Yungang Ding; Jie Li; Cheng Yang; Yan Luo; Shiqing Li; Gang Sun; Xulong Liao; Wang Min
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

4.  Tetramethylpyrazine decreases hypothalamic glutamate, hydroxyl radicals and prostaglandin-E2 and has antipyretic effects.

Authors:  Chin-Hong Chang; Wu-Tein Huang; Cheng-Hsing Kao; Sheng-Hsien Chen; Cheng-Hsien Lin
Journal:  Inflamm Res       Date:  2013-03-23       Impact factor: 4.575

5.  Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.

Authors:  Haidy E Michel; Mariane G Tadros; Ahmed Esmat; Amani E Khalifa; Ahmed M Abdel-Tawab
Journal:  Mol Neurobiol       Date:  2016-08-11       Impact factor: 5.590

Review 6.  Ligustrazine monomer against cerebral ischemia/reperfusion injury.

Authors:  Hai-Jun Gao; Peng-Fei Liu; Pei-Wen Li; Zhuo-Yan Huang; Feng-Bo Yu; Ting Lei; Yong Chen; Ye Cheng; Qing-Chun Mu; Hai-Yan Huang
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

Review 7.  Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials.

Authors:  Ibrahim Jantan; Waqas Ahmad; Syed Nasir Abbas Bukhari
Journal:  Front Plant Sci       Date:  2015-08-25       Impact factor: 5.753

Review 8.  Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease.

Authors:  Sandeep Vasant More; Hemant Kumar; Seong Mook Kang; Soo-Yeol Song; Kippeum Lee; Dong-Kug Choi
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-01       Impact factor: 2.629

9.  GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF- κ B Pathways in LPS-Stimulated Microglial Cells.

Authors:  Gai-Ying He; Chong-Gang Yuan; Li Hao; Ying Xu; Zhi-Xiong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-24       Impact factor: 2.629

10.  Vaccinium bracteatum Thunb. Exerts Anti-Inflammatory Activity by Inhibiting NF-κB Activation in BV-2 Microglial Cells.

Authors:  Seung-Hwan Kwon; Shi-Xun Ma; Yong-Hyun Ko; Jee-Yeon Seo; Bo-Ram Lee; Taek Hwan Lee; Sun Yeou Kim; Seok-Yong Lee; Choon-Gon Jang
Journal:  Biomol Ther (Seoul)       Date:  2016-09-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.